Abrams Capital

Superinvestor

Abrams Capital Management, L.P.

SEC CIK: 0001358706
Manager: David Abrams
Style: Value
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Abrams Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overview All 13F holders of HZNP Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q2 2023

Holdings of HZNP by Abrams Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−890,993−100.0%	Sold out	Holders
Q2 2023	890,993	$91.6M	2.6%	+890,993	New	Holders